#Semaglutide is an active hashtag on Bluesky. In the last 30 days, 30 people shared 43 posts with it — around 1 a day. Activity is up 0% versus the previous week, peaking on Jul 16 with 6 posts.

Posts with #Semaglutide

Susan Wilkinson; artist

@swilk.bsky.social

over 1 year ago

Pretty sure I need more coffee this afternoon; fatigue is hitting me hard #semaglutide #coffee #art colorbysusan.etsy.com/lis….

Original acrylic artwork hand painted by chronically tired disabled artist. Coffee cup & saucer with background of coffee beans

1 0 39

Meechol

@meeechol.bsky.social

over 1 year ago

I’m down 23 pounds today. It’s hard to see the difference in the mirror everyday, so I’m thankful for my progress pics. My bed is still not made, btw. #glp1 #progress #glp1journey #semaglutide #gay #bear #gaybear

0 1 37

The Lancet Diabetes & Endocrinology

@thelancetendo.bsky.social

about 11 hours ago

New—Effect of #semaglutide on #kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis thelancet.com/journals/lan... #T2D #CKD #CVD #MedSky #EndoSky #RenalSky #CardioSky

thelancet.com

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis

Data pooled from three large phase 3 trials suggest that semaglutide reduces the risk of major kidney outcomes in a broad population with cardio–kidney–metabolic disease while having a favourable risk...

0 0 3

midgardfinance.com

@midgardfinance.com

2 days ago

🇩🇰 $NOVO is close to a one-molecule company. Semaglutide is 76% of sales worldwide and 87% in the US. #Ozempic alone is 40% of the company, #Wegovy injectable another 25%. Insulin and rare disease together are the remainder. midgardfinance.com/compan… #pharma #semaglutide $NVO

Three line charts side by side on a dark background, titled "Novo Nordisk semaglutide as a share of sales". The panels are World, US and Ex-US. The vertical axis is share of all Novo Nordisk sales, from zero to about ninety percent, and each panel runs from late 2020 to mid 2026.

Three lines in each panel. Violet is semaglutide counted across all its brands, which are Ozempic, Wegovy injectable, Wegovy pill and the oral diabetes tablet sold as Rybelsus or Ozempic pill. Light blue is Ozempic alone. Green is Wegovy injectable alone.

Worldwide, semaglutide climbs from under 20 percent in 2020 to 76 percent of all company sales. Ozempic alone rises to about 40 percent and has been flat for roughly two years. Wegovy injectable climbs steadily to about 25 percent.

In the US the same lines are higher and further along: semaglutide reached about 90 percent during 2025 and stands near 87 percent, having eased back from its peak. Ex-US semaglutide is lower at about 63 percent but still rising, and the Wegovy line there is still climbing steeply rather than levelling off.

The three panels together show one company increasingly dependent on a single molecule, with the US furthest into that dependence and the rest of the world following.

1 0 3

Prof Claire Hills

@chillslincoln79.bsky.social

over 1 year ago

📣 Novo Nordisk announces that the FDA has granted approval to its blockbuster drug Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes. 👩‍🔬🥼🧪👨‍🔬 #Semaglutide #diabetes #type2diabetes #nephropathy #GLP-1 👇👇 docwirenews.com/post/fda-….

docwirenews.com

FDA Approves Ozempic for Kidney Disease | Docwire News

Based on FLOW trial results, the FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.

2 5 29

Terra Field

@rainofterra.gay

almost 2 years ago

LOL FINALLY Anybody who has been on it knew everything they said about how it worked was wrong but we didn’t care because it was incredible. It actually raises the basal metabolic rate, which for me was always incredibly low when I got it tested. Not anymore! 🎉 #semaglutide #wegovy #ozempic

www.newsweek.com

Ozempic works differently than previously thought, study reveals

Ozempic, Wegovy, Mounjaro and other weight loss drugs work by boosting metabolism and suppressing appetite, a new trial suggests.

7 3 27

Dan Brierley

@drdanbrierley.bsky.social

11 months ago

Proud PI moment #2: Superstar postdoc @laurenjonesucl.bsky.social absolutely smashing her first conference presentation of her fascinating data on #semaglutide mechanism of action. #BSNBradford2025

1 3 27

Prof Claire Hills

@chillslincoln79.bsky.social

over 1 year ago

More coverage around Semaglutide and it's ability to reduce kidney disease progression by 22% and cardiovascular risk in an analysis involving >85,000 👩‍🔬🧪🥼👨‍🔬. #GLP-1 #semaglutide #diabetes #kidneydisease #Nephropathy #CardioSky #NephSky #MedSky 👇👇👇 www.theguardian.com/scien….

www.theguardian.com

Weight-loss drugs can improve kidney health, study finds

Analysis involving more than 85,000 people showed risk of worsening function was reduced by 22%

2 3 23

Prof Paul E Squires

@paulsquires.bsky.social

over 1 year ago

Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials 👇👇👨‍🔬🧪🥼 #cardiacsky #nephsky #medsky #cardiovascular #kidneydisease #Type2diabetes #semaglutide www.ajkd.org/article/S027...

www.ajkd.org

DEFINE_ME

1 6 23

Mrs Chippy🏳️‍🌈🏳️‍⚧️

@mrschippy.bsky.social

2 months ago

After 10 weeks on Wegovy I am 6.5 kg lighter. Apparently this translates into 26 kg less loading on my knee, which has to be good. My knee doesn’t seem to have got the memo yet, but I’ll persevere. This medication really needs to be funded. #GLP1 #semaglutide #kikorangi

4 0 22

𝕖𝕔𝕜𝕤𝕥𝕖𝕚𝕟

@ecksteinish.bsky.social

11 months ago

#Semaglutide Update, Day 5: When they say these injections kill your appetite, they weren't kidding. I have to remind myself to eat, even if it's just a protein shake. Leftover pizza sitting in the fridge and I haven't even been tempted. Down 2 lbs so far, which is a "safe" loss per week. #GLP1

2 0 21

Prof Claire Hills

@chillslincoln79.bsky.social

over 1 year ago

📣 Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-clinical trial @naturemedicine.bsky.social 👩‍🔬🥼🧪👨‍🔬 #Semaglutide #KidneyDisease #Obesity #kidney #NephroSky #CardioSky #NephSky 👇👇👇 pubmed.ncbi.nlm.nih.gov/3…

pubmed.ncbi.nlm.nih.gov

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial - PubMed

Semaglutide reduces albuminuria and the risk of kidney disease progression in patients with type 2 diabetes and chronic kidney disease (CKD). We conducted a randomized placebo-controlled double-blind ...

0 8 21